Airain Ltd’s Dr. Reddy's Laboratories RDY Stock Holding History

Airain Ltd’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$223K	Buy	+26,405	New	+$215K	0.01%	730
2016 Q3	–	Sell	-64,705	Closed	-$663K	–	768
2016 Q2	$663K	Buy	+64,705	New	+$593K	0.04%	397
2015 Q3	–	Sell	-67,770	Closed	-$750K	–	1030
2015 Q2	$750K	Sell	67,770 -68,245	-50%	-$753K	0.04%	416
2015 Q1	$1.55M	Buy	+136,015	New	+$1.44M	0.09%	240
2014 Q3	–	Sell	-40,620	Closed	-$351K	–	956
2014 Q2	$351K	Buy	+40,620	New	+$342K	0.03%	508

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Airain Ltd's RDY Position: Q2 2017 in Review

Airain Ltd opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2017: 26,405 shares worth $223K. The stake represents 0.01% of the portfolio and ranks #730 among its holdings. This is a return to the name: Airain Ltd previously reported a position in RDY as recently as Q2 2016.

Airain Ltd first reported a position in RDY in Q2 2014 and has held it in 5 quarters since. The position peaked at $1.55M in Q1 2015. 128 funds tracked by Wall St. Rank hold RDY as of Q2 2017.

Airain Ltd held 26,405 shares of Dr. Reddy's Laboratories worth $223K as of Q2 2017.
Dr. Reddy's Laboratories was a new Airain Ltd position in Q2 2017.
Dr. Reddy's Laboratories made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #730 holding.
Airain Ltd first reported a position in Dr. Reddy's Laboratories in Q2 2014 and has held it in 5 quarters since.
Airain Ltd's Dr. Reddy's Laboratories position peaked at $1.55M in Q1 2015.
128 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.